A Biobank for Functional Gastrointestinal Disorders (FGID)
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 12-000948
Sponsor Protocol Number: 12-000948
About this study
The purpose of this study is to develop a resource (bank) of biospecimens and data collected from individuals with functional gastrointestinal disorders (FGID) to facilitate discovery and development of novel microbial biomarkers of disease and response to treatment, and novel targeted therapeutic strategies for FGID.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult patients attending any of the gastroenterology or other medical outpatient clinics at the Rochester campus with a diagnosis of any functional gastrointestinal disorder (FGID) will be eligible for enrollment
- Age ≥ 18
Exclusion Criteria:
- Individuals who do not comprehend English (i.e., participants must be able to read and sign a consent form without the assistance of an interpreter)
- Age <18
- Individuals who are unable to sign consent (e.g., mentally challenged, those declared legally incompetent)
- Individuals regarded as belonging to a vulnerable population (e.g., prisoners)
- Patients will be ineligible to deposit a stool sample if they have had antibiotics within the last month, they can however deposit fecal samples after a washout period
- Any other disease(s), condition(s) or habit(s) that would interfere with completion of study, would increase risks, or in the judgment of the investigator would potentially interfere with compliance to this study or would adversely affect study outcomes
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Purna Kashyap, M.B.B.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available